|  |    Number of |    Percent with |  |  | ||
---|---|---|---|---|---|---|---|
Outcome | Comparator |    Trials |    Patients | Ferric carboxymaltose |    Control | RB 95% CI | NNT 95% CI |
Target ferritin increase | All |    3 |    611 |    61 |    43 |    1.6 (1.3 to 1.9) |    5.6 (3.9 to 10) |
 | Oral iron |    2 |    428 |    59 |    22 |    2.7 (2.0 to 3.6) |    2.7 (2.2 to 3.6) |
Target TSAT increase | All |    3 |    611 |    65 |    62 |    1.1 (0.9 to 1.2) |    not calculated |
 | Oral iron |    2 |    428 |    64 |    59 |    1.1 (0.9 to 1.3) |    not calculated |